Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 3 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Results 1 - 20 of 191 : 1 2 3 4 5 6 7 8 9 10 Next »

Recs

0
Member Avatar pchop123 (78.31) Submitted: 4/4/2014 1:23:35 PM : Outperform Start Price: $59.45 LLY Score: +2.05

good numbers incl YLD

Recs

0
Member Avatar afewgoodstocks11 (33.96) Submitted: 2/18/2014 6:56:52 PM : Outperform Start Price: $36.47 LLY Score: +20.80

Div. (Yield) $1.96 (3.6%)
Current Yield . . . . . 5.37%

Recs

0
Member Avatar DrydenTexas (91.96) Submitted: 1/21/2014 10:42:58 AM : Outperform Start Price: $55.03 LLY Score: +8.11

gblc

Recs

0
Member Avatar theActuary (34.69) Submitted: 1/14/2014 8:00:24 AM : Outperform Start Price: $51.67 LLY Score: +14.69

LLY woot

Recs

0
Member Avatar knockripper (20.94) Submitted: 11/15/2013 9:20:56 AM : Outperform Start Price: $50.41 LLY Score: +16.06

Great Company, health care reform.

Recs

0
Member Avatar jmpeavler (< 20) Submitted: 8/12/2013 5:54:29 PM : Underperform Start Price: $54.95 LLY Score: +0.05

most of their drugs have gone genetic. A couple of new ones (diabetes and dementia) don't seem to be making much progress with testing. good dependable dividends.

Recs

1
Member Avatar Teacherman333 (71.75) Submitted: 6/1/2013 1:14:36 PM : Outperform Start Price: $52.77 LLY Score: +0.31

For reference point and to allow for comments by others. As of the end of March, 2013.

ROE 31.07%
Trailing PE 12.78
PB 3.92
Div yield 3.60%

Recs

1
Member Avatar 6sigmaford (34.02) Submitted: 11/15/2012 12:02:53 PM : Outperform Start Price: $43.70 LLY Score: +0.65

Diabetes will be around a long time and so will Lilly.

Recs

0

Recs

0
Member Avatar GVA1 (< 20) Submitted: 10/14/2012 9:58:32 AM : Outperform Start Price: $48.14 LLY Score: -4.61

Surprising success in Alzheimer's portfolio

Recs

0
Member Avatar TMFBiologyFool (98.65) Submitted: 10/12/2012 12:25:24 PM : Underperform Start Price: $47.76 LLY Score: +4.01

Over exuberance for Alzheimer's program.

Recs

0
Member Avatar FoolWithFive (99.40) Submitted: 7/25/2012 12:04:25 PM : Outperform Start Price: $40.60 LLY Score: +9.53

They are the heart and soul of indianapolis. This company does great things for the state of Indiana and health care!

Recs

1
Member Avatar einzling44 (23.63) Submitted: 5/15/2012 4:04:46 AM : Underperform Start Price: $38.21 LLY Score: -19.08

cap spending ahead

Recs

0
Member Avatar slih (< 20) Submitted: 1/26/2012 12:58:31 AM : Outperform Start Price: $36.43 LLY Score: +25.92

veternary products; retained corporate brainpower

Recs

0
Member Avatar fooluser17 (37.58) Submitted: 1/19/2012 2:04:19 PM : Outperform Start Price: $36.66 LLY Score: +23.09

Dividend rockstar, most numbers are good. Probably make this one 1%.

Recs

0
Member Avatar jesseangels (< 20) Submitted: 1/13/2012 7:41:59 PM : Outperform Start Price: $36.65 LLY Score: +21.58

Undervalued. Target ~50$.

Recs

0
Member Avatar guinness4life (63.12) Submitted: 12/21/2011 6:21:56 PM : Outperform Start Price: $38.12 LLY Score: +8.96

Long this. Gorgeous value stock with great dividend. I got in a few months ago. Get in the next time a drug misses approval.

Recs

0
Member Avatar GETRICHSLOW2 (81.73) Submitted: 12/12/2011 10:16:26 PM : Outperform Start Price: $35.64 LLY Score: +20.27

Falling off the patent cliff but the metrics look outstanding. A great time to buy in. Company has been around since 1901. I doubt they will go under just because of a few patent expirations. Currently yielding 5%. p/e=8.5, payout ratio=43%, beta= 0.67.

Buy Buy Buy!

Recs

0
Member Avatar Divlover (70.36) Submitted: 12/8/2011 4:09:44 PM : Outperform Start Price: $35.54 LLY Score: +19.64

Possible Alzhiemer drug in the works and a nice dividend.

Recs

0
Member Avatar SearchS (43.29) Submitted: 12/6/2011 9:27:59 PM : Outperform Start Price: $35.84 LLY Score: +20.49

Promising drugs in the pipeline...

Featured Broker Partners


Advertisement